Ignite Creation Date:
2024-05-06 @ 8:27 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06395753
Status:
RECRUITING
Last Update Posted:
2024-06-25
First Post:
2024-04-29
Brief Title:
A Dose Finding Study of Debio 4228 in Participants With Locally AdvancedMetastatic Prostate Cancer
Sponsor:
Debiopharm International SA
Organization:
Debiopharm International SA
Study Overview
Official Title:
A Phase 2 Randomized Open-Label Dose-Finding Study of Debio 4228 an Extended-Release Formulation of Gonadotropin-Releasing Hormone Antagonist in Participants With Locally AdvancedMetastatic Prostate Cancer
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary purpose of this study is to determine the pharmacokinetics PK and pharmacodynamics PD of Debio 4228
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2024-511038-11 | OTHER | EU CT Number | None |
| U1111-1298-8943 | OTHER | None | None |